Medicare Part D subsidy program will end in 2027: Here’s what to know
FILE - Prescription medication strewn out on U.S. currency. (Getty Images)
The Trump administration announced on Tuesday it will move to end a temporary subsidy under Medicare Part D, a Biden-era program that aimed to keep premiums stable for prescription drug plans.
The administration claimed the subsidy only benefited private insurance companies that offered the coverage but did not actually help enrollees.
What is Medicare Part D?
Medicare Part D provides prescription drug coverage for millions of people through private insurance plans.
Regular Medicare, which most people qualify for after turning 65, does not come with prescription coverage, known as Part D. People must choose that separately.
The optional coverage helps people pay for brand-name and generic medications.
Another roughly 34 million people have Medicare Advantage plans, which are privately run versions of Medicare that often come with prescription coverage.
Why you should care:
The subsidy will no longer be offered under Medicare Part D in 2027, which means millions of older Americans could face higher Medicare drug premiums next year.
"It’s certainly possible that without this enhanced financial support in place for 2027, some Medicare beneficiaries enrolled in [Part D plans] could face relatively steep premium increases for drug coverage next year," Juliette Cubanski, director of KFF’s program on Medicare policy, told The Washington Post.
Insurance companies that offer the subsidy include UnitedHealth Group, Humana, and Aetna, according to Reuters.
The Source: Information for this article was taken from reporting by The Hill, Reuters, The Washington Post, The New York Times, The Associated Press and a tweet posted by Dr. Oz on July 28, 2026. Information from the Centers for Medicare & Medicaid Services also contributed. This story was reported from San Jose.